Matched unrelated donor transplant
Showing 1 - 25 of >10,000
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Chicago (Haplo-Cord Transplant, Matched Unrelated Donor
Terminated
- Acute Myeloid Leukemia (AML)
- Myelodysplastic Syndrome (MDS)
- Haplo-Cord Transplant
- Matched Unrelated Donor Transplant
-
Chicago, IllinoisUniversity of Chicago Cancer Center
Feb 22, 2021
Severe Aplastic Anemia Trial in United States (drug, procedure, radiation)
Active, not recruiting
- Severe Aplastic Anemia
- cyclosporine
- +8 more
-
Los Angeles, California
- +12 more
Feb 10, 2022
SIOD With CKD Stage 3 Through 5, Cystinosis With CKD Stage 3 Through 5, FSGS With CKD Stage 3 Through 5 Trial in Palo Alto
Not yet recruiting
- SIOD With CKD Stage 3 Through 5
- +3 more
- Cyclophosphamide 1200 mg/Kg
- +8 more
-
Palo Alto, CaliforniaLucile Packard Children's Hospital
Aug 17, 2022
Hematologic Diseases Trial in Palo Alto (Allogeneic Stem Cell Transplant, CliniMACS TCR a/ß Reagent Kit and CliniMACS CD19)
Recruiting
- Hematologic Diseases
- Allogeneic Stem Cell Transplant
- CliniMACS TCR α/β Reagent Kit and CliniMACS CD19
-
Palo Alto, CaliforniaLucile Packard Children's Hospital
Feb 2, 2022
Leukemia, Lymphoma, Myelodysplasia Trial in Philadelphia (Alpha Beta T cell depletion)
Recruiting
- Leukemia
- +2 more
- Alpha Beta T cell depletion
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Oct 27, 2021
Chronic Granulomatous Disease, CGD Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (JSP191)
Recruiting
- Chronic Granulomatous Disease
- CGD
- JSP191
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 5, 2023
DOCK8 Deficiency Trial run by the National Cancer Institute (NCI) (Reduced-intensity hematopoietic stem cell,
Recruiting
- DOCK8 Deficiency
- Reduced-intensity hematopoietic stem cell
- +6 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 27, 2023
Sickle Cell Disease Trial in Duarte (drug, procedure, radiation)
Recruiting
- Sickle Cell Disease
- Alemtuzumab
- +3 more
-
Duarte, CaliforniaCity of Hope Comprehensive Cancer Center
Jul 31, 2022
Severe Combined Immune Deficiency (SCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)
Enrolling by invitation
- Severe Combined Immune Deficiency (SCID)
- Sirolimus
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
Acute Leukemia, Acute Lymphocytic Leukemia, Acute Myelogenic Leukemia Trial (Haploidentical hematopoietic cell transplantation
Not yet recruiting
- Acute Leukemia
- +4 more
- Haploidentical hematopoietic cell transplantation (haploHCT)
- matched unrelated donor hematopoietic cell transplantation (MUD-HCT)
- (no location specified)
Jul 13, 2022
Acute Myeloid Leukemia, Advanced MDS Trial in New York (Busulfan, Melphalan, Fludarabine, Anti-Thymocyte Globulin, Palifermin,
Completed
- Acute Myeloid Leukemia
- Advanced Myelodysplastic Syndromes
- Busulfan, Melphalan, Fludarabine, Anti-Thymocyte Globulin, Palifermin, Stem cell transplant
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Aug 27, 2021
Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome Trial in Maywood (Cyclophosphamide, Tacrolimus,
Recruiting
- Acute Myeloid Leukemia
- +4 more
- Cyclophosphamide
- +3 more
-
Maywood, IllinoisLoyola University Medical Center
Apr 22, 2021
Blood Disease Trial (TCRaß+/CD19+ depleted Hematopoietic stem cell (HSC) graft, CliniMACS® System)
Not yet recruiting
- Blood Disease
- TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC) graft
- CliniMACS® System
- (no location specified)
Jan 30, 2023
Myelodysplastic Syndrome, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Bethesda, Minneapolis (biological, drug,
Recruiting
- Myelodysplastic Syndrome
- +4 more
- Rituximab
- +6 more
-
Bethesda, Maryland
- +1 more
Aug 20, 2022
Immunodeficiencies Trial in Philadelphia (CliniMACs)
Active, not recruiting
- Immunodeficiencies
- CliniMACs
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Mar 1, 2022
Acquired Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria, Inherited Bone Marrow Failure Syndromes Trial in Philadelphia
Recruiting
- Acquired Aplastic Anemia
- +2 more
- CliniMACs
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Mar 1, 2022
Score in Matched Unrelated or Haploidentical Hematopoietic Stem
Completed
- Hematopoietic Stem Cell Transplantation
- +2 more
-
Saint Louis, Missouri
- +3 more
Feb 2, 2021
Immunodeficiencies, Immune Dysregulation Syndromes Trial in Philadelphia (Apha/beta T and CD19+ cell depletion using CliniMACS
Recruiting
- Immunodeficiencies
- Immune Dysregulation Syndromes
- Apha/beta T and CD19+ cell depletion using CliniMACS device
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Nov 8, 2022
Idiopathic Aplastic Anemia, Severe Aplastic Anemia, Moderate Aplastic Anemia Requiring Transfusions Trial (HSCT Arm group)
Not yet recruiting
- Idiopathic Aplastic Anemia
- +2 more
- HSCT Arm group
- (no location specified)
Jun 10, 2022
Haematological Malignancies Trial in London, Manchester (CD25/71 allodepleted donor T-cells)
Completed
- Haematological Malignancies
- CD25/71 allodepleted donor T-cells
-
London, United Kingdom
- +1 more
Jul 18, 2022
Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))
Not yet recruiting
- Leukemia
- +12 more
- Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
- (no location specified)
Mar 20, 2023
Immune Tolerance Trial in Palo Alto, Madison (Immune tolerance after kidney transplant, Donor blood stem cells and T cells)
Recruiting
- Immune Tolerance
- Immune tolerance after kidney transplant
- Donor blood stem cells and T cells
-
Palo Alto, California
- +1 more
Jul 15, 2020